Table 1.
Demographic information and clinical characteristics of both groups
| Characteristics | ICPs (n=24) | Controls (n=24) |
| Age, years | 64.8±12.5 | 64.6±12.1 |
| Gender, n (%) | ||
| Male | 15 (62.5) | 15 (62.5) |
| Female | 9 (37.5) | 9 (37.5) |
| Symptoms,a n (%) | ||
| Cough | 7 (29.2) | 11 (45.8) |
| Sputum | 8 (33.3) | 11 (45.8) |
| Dyspnoea | 2 (8.3) | 4 (16.7) |
| Haemoptysis | 2 (8.3) | 2 (8.3) |
| Weight loss | 0 (0) | 3 (12.5) |
| Fever | 5 (20.8) | 1 (4.2) |
| Organisms, n (%) | ||
| Mycobacterium avium | 8 (33.3) | 8 (33.3) |
| M. intracellulare | 8 (33.3) | 7 (29.2) |
| M. abscessus | 5 (20.8) | 7 (29.2) |
| M. kansasii | 3 (12.5) | 2 (8.3) |
ICP, immunocompromised patients.
a
Symptoms lasting longer than 2 weeks are indicated. Some patients had more than one symptom.